Literature DB >> 15194665

Bone density loss in Crohn's disease: role of TNF and potential for prevention by bupropion.

R E Kast, E L Altschuler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15194665      PMCID： PMC1774110     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  13 in total

1.  Remission of Crohn's disease on bupropion.

Authors:  R E Kast; E L Altschuler
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

2.  Positive cytokine production in failed metal-on-metal total hip replacements.

Authors:  Patricia A Campbell; Mark Wang; Harlan C Amstutz; Stuart B Goodman
Journal:  Acta Orthop Scand       Date:  2002-10

3.  Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta2-microglobulin, and clinical stage in multiple myeloma.

Authors:  Vladimir Jurisić; Milica Colović
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

4.  New indications for treatment of chronic inflammation by TNF-alpha blockade.

Authors:  Andreas M Reimold
Journal:  Am J Med Sci       Date:  2003-02       Impact factor: 2.378

Review 5.  The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction.

Authors:  D T Graves; D Cochran
Journal:  J Periodontol       Date:  2003-03       Impact factor: 6.993

Review 6.  The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation.

Authors:  Clifton O Bingham
Journal:  J Rheumatol Suppl       Date:  2002-09

Review 7.  Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.

Authors:  S R Goldring
Journal:  Rheumatology (Oxford)       Date:  2003-05       Impact factor: 7.580

8.  Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha.

Authors:  F Allali; M Breban; R Porcher; J F Maillefert; M Dougados; C Roux
Journal:  Ann Rheum Dis       Date:  2003-04       Impact factor: 19.103

9.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Authors:  Christopher T Ritchlin; Sally A Haas-Smith; Ping Li; David G Hicks; Edward M Schwarz
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 10.  Evaluation of bone mineral density in inflammatory bowel disease: current safety focus.

Authors:  Gary R Lichtenstein
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864
View more
  4 in total

1.  Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations.

Authors:  Paul A Rufo; Lee A Denson; Francisco A Sylvester; Eva Szigethy; Pushpa Sathya; Ying Lu; Ghassan T Wahbeh; Laureen M Sena; William A Faubion
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-07       Impact factor: 2.839

2.  Antidepressants and inflammatory bowel disease: a systematic review.

Authors:  Antonina A Mikocka-Walus; Deborah A Turnbull; Nicole T Moulding; Ian G Wilson; Jane M Andrews; Gerald J Holtmann
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-09-20

3.  Synthesis, screening and pharmacokinetic evaluation of potential prodrugs of bupropion. Part one: in vitro development.

Authors:  Paul Matthew O'Byrne; Robert Williams; John J Walsh; John F Gilmer
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-14

4.  Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

Authors:  Paul Matthew O'Byrne; Robert Williams; John J Walsh; John F Gilmer
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.